FIGURE

Fig. 2

ID

ZDB-FIG-250813-30

Publication

Zimmerman et al., 2025 - Investigating Psychopharmaceutical Effects on Early Vertebrate Development Using a Zebrafish Model System

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

(A–F) LC-MS/MS analysis of cholesterol precursors and cholesterol following exposure to AY9944 and psychopharmaceuticals. Cholesterol precursor and cholesterol levels were measured in AY9944, CAR, ARI, and TRZ-treated zebrafish. Results are presented as relative fold change normalized to the vehicle (VEH)-treated zebrafish. (A) Lanosterol, (B) 7-DHC, (C) cholesterol, (D) desmosterol, (E) 7-DHC/cholesterol, (F) desmosterol/cholesterol. N ≥ 3 trials with at least three technical replicates, 30 fish per condition for each trial. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, determined by one-way ANOVA followed by Tukey’s post hoc HSD. VEH= 0.1% DMSO, AY9944 = positive control, CAR = Cariprazine, ARI = Aripiprazole, TRZ = Trazodone. Error Bars = 95% confidence intervals.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Dev Biol